According to GuruFocus Insider Data, the recent CFO buys were: ADMA Biologics Inc (ADMA, Financial) and Healthcare Trust of America Inc. (HTA, Financial).
ADMA Biologics Inc: Vice President and Chief Financial Officer Brian Lenz bought 5,000 shares
Vice President and Chief Financial Officer Brian Lenz bought 5,000 shares for $4.78 per share on June 8. Since then, the stock price has decreased by 1.67%. ADMA Biologics Inc. has a market cap of $172.610 million and its shares were traded around $4.70. The company has a price-sales ratio of 6.33. Over the past five years, ADMA Biologics Inc. had an annual average earnings growth of 2.80%.
ADMA Biologics announced its first-quarter results with revenue of $4.04 billion and gross loss of $8.2 billion, while the net loss was $17.82 billion. The 2017 total revenue was $22.76 billion, a 113% increase from 2016. The 2017 gross loss was $6.4 billion, a 249% decrease from the year prior. The 2017 net loss was $43.76 billion.
President and CEO Adam S. Grossman bought 73,222 shares for $4.78 per share on June 08. Since then, the stock price has decreased by 1.67%. Director Jerrold B. Grossman bought 52,302 shares for $4.78 per share on June 8. Since then, the stock price has decreased by 1.67%. Director Lawrence P. Guiheen bought 20,000 shares for $4.78 per share on June 8. Since then, the stock price has decreased by 1.67%.
Healthcare Trust of America Inc: CFO Robert A. Milligan bought 3,800 shares
CFO Robert A. Milligan bought 3,800 shares for $25.35 per share on June 8. Since then, the stock price has decreased by 0.87%. Healthcare Trust of America Inc. has a market cap of $5.16 billion and its shares were traded around $25.13. The company has a price-earnings ratio of 81.06 and P/S ratio of 7.58. The trailing 12-month dividend yield of Healthcare Trust of America Inc. stocks is 4.83%, while the forward dividend yield is 4.83%. Over the past five years, Healthcare Trust of America Inc. had an annual average earnings growth of 9.60%.
Healthcare Trust of America announced its first-quarter results with revenue of $175.66 million and gross profit of $119.64 million, while the net income was $9.90 million. The 2017 total revenue was $613.99 million, a 33% increase from 2016. The 2017 gross profit was $421.84 million, a 33% increase from the year prior. The 2017 net income was $65.35 million.
Director Warren D. Fix bought 1,000 shares for $25.28 per share on June 8. Since then, the stock price has decreased by 0.59%. Director Daniel S. Henson bought 1,000 shares for $25.27 per share on June 8. Since then, the stock price has decreased by 0.55%. Director Peter N. Foss bought 1,000 shares for $24.98 per share on June 8. Since then, the stock price has increased by 0.6%.
Disclosure: None.
